Anchalee Vattarakorn

Anchalee Vattarakorn

Auto-generated profile, based on publicly available information

Anchalee Vattarakorn

Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
NRNattapon Rotpenpian
Nattapon Rotpenpian
STSompol Tapechum
Sompol Tapechum
AVAnchalee Vattarakorn
Anchalee Vattarakorn
WCWongsathit Chindasri
Wongsathit Chindasri
CCChit Care
Chit Care
AWAree Wanasuntronwong
Aree Wanasuntronwong
Mirror-image pain is a kind of pain that occurs on the contralateral side, but its pathogenesis remains unclear. Objective To develop an osteoarthritis mouse model for investigating mirror-image pain through observing nocifensive behaviors, histological changes, and nociceptive activity at days 3, 7, 14, 21, and 28 after the chemical induction of unilateral temporomandibular joint (TMJ) osteoarthritis. Methodology We randomly divided 6-week-old mice into sham and complete Freund adjuvant groups. To induce nocifensive behaviors, we applied 0.04 g of von Frey filament, 10 psi of air puff, and cold acetone on both sides of whisker pads at different days. The histology of TMJ on both sides was observed by hematoxylin/eosin staining and microcomputed tomography scanning. Furthermore, the nociceptive activity was evaluated using the phosphorylated cyclic AMP response element binding protein (pCREB) and a microglia marker at different days in the trigeminal subnucleus caudalis. Results Nocifensive behaviors against mechanical and temperature stimuli on the contralateral side became stronger than the baseline on day 28, in agreement with the elevation of the pCREB and the microglia marker in the trigeminal subnucleus caudalis. Thus, hypernociception on the contralateral side occurred at day 28. Conclusions Clearly, the TMJ model with unilateral osteoarthritis exhibited mirror-image pain. Therefore, this model is useful in investigating the pathogenesis of pain and in developing treatments.

23 September 2025 in Veterinary World
Verified
Journal Article
Open access
JRJutamas Ruanpang
Jutamas Ruanpang
NTNamphung Thongta
Namphung Thongta
AVAnchalee Vattarakorn
Anchalee Vattarakorn
SNSukonthar Ngampramuan
Sukonthar Ngampramuan
PPPornjira Pariwatcharakul
Pornjira Pariwatcharakul
NPNarawut Pakaprot
Narawut Pakaprot
Background and Aim: Major depressive disorder is a prevalent psychiatric condition associated with impaired neuroplas­ticity, particularly in the hippocampus. Although selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed, their delayed onset and adverse effects highlight the need for alternative therapies. Cannabidiol (CBD), a non-psychotomi­metic cannabinoid, has shown antidepressant-like properties, but its mechanistic link to hippocampal synaptic plasticity remains unclear. This study aimed to evaluate the effects of CBD on depression-like behaviors and hippocampal neuroplas­ticity in rats subjected to chronic restraint stress (CRS). Materials and Methods: Sixty male Wistar rats were randomly divided into six groups: Non-stressed vehicle (NV), CRS vehi­cle (SV), escitalopram-treated CRS (SE, 10 mg/kg), and CBD-treated CRS at 10, 30, or 100 mg/kg (SC10, SC30, and SC100). Rats were subjected to CRS for 28 days and treated daily through intraperitoneal injection. Depression-like behaviors were assessed using the forced swim test (FST) and sucrose preference test (SPT). Locomotor activity was evaluated through the open-field test (OFT). Hippocampal dendritic spine density (Golgi–Cox staining) and long-term potentiation (LTP, electro­physiology) were measured on day 28. Results: CRS induced behavioral despair (↑ immobility in FST) and anhedonia (↓ sucrose preference in SPT), accompanied by reduced hippocampal spine density. At all doses, CBD significantly reduced immobility, comparable to escitalopram. Notably, only CBD at 100 mg/kg and escitalopram reversed anhedonia. All CBD-treated groups showed an increase in den­dritic spine density, with SC10 producing the greatest enhancement. Moreover, CBD at 100 mg/kg markedly improved hippocampal LTP at 1 h and 2 h post-stimulation, an effect not observed with escitalopram. Locomotor activity remained unaffected. Conclusion: CBD demonstrated potent antidepressant-like effects in a CRS rat model, alleviating behavioral despair and anhedonia while enhancing hippocampal dendritic spine density and synaptic strength. These findings suggest CBD as a promising candidate for stress-related mood disorders, with mechanistic actions distinct from conventional SSRIs and potential utility in patients unresponsive to current therapies. Keywords: cannabidiol, chronic stress, depression, hippocampus, long-term potentiation, synaptic plasticity.

11 August 2026 in Veterinary World
Verified
Journal Article
Open access
WSWachirapong Saleeon
Wachirapong Saleeon
AVAnchalee Vattarakorn
Anchalee Vattarakorn
NTNamphung Thongta
Namphung Thongta
YBYingrak Boondam
Yingrak Boondam
AWAree Wanasuntronwong
Aree Wanasuntronwong
NPNarawut Pakaprot
Narawut Pakaprot
Background and Aim: Spontaneous intracerebral hemorrhage (sICH) is a devastating subtype of stroke characterized by high mortality, severe neurological disability, and limited effective pharmacological treatment. Secondary brain injury following sICH is largely driven by excessive neuroinflammation, in which activated microglia predominantly adopt a pro-inflammatory (M1-like) phenotype that exacerbates neuronal damage. The voltage-gated potassium channel Kv1.3 is highly expressed in activated microglia and represents a promising therapeutic target for modulating neuroinflammatory responses. This study investigated whether selective Kv1.3 inhibition with 5-(4-phenoxybutoxy) psoralen (PAP-1) could promote immuno-modulatory microglial polarization, attenuate brain injury, and improve neurological recovery in a collagenase-induced mouse model of sICH. Materials and Methods: Adult male ICR mice with collagenase-induced sICH received daily intraperitoneal administration of PAP-1 (40 mg/kg) or vehicle for up to 7 days. Survival, body weight, hematoma volume, neuronal survival, Kv1.3 expression, and microglial polarization were evaluated using histological and immunohistochemical analyses. Neurological recovery was assessed using the modified neurological severity score, cylinder test, corner turn test, and open field test. Histological analyses were performed on post-injury days 1, 2, 3, and 7, whereas behavioral assessments and survival monitoring were conducted longitudinally throughout the experimental period. Results: Selective Kv1.3 inhibition significantly improved neurological recovery following sICH. PAP-1 treatment increased 7-day survival from 40% to 70% and significantly reduced hematoma volume from day 2 onward, with reductions of approximately 19% on days 2 and 3 and 24% on day 7 compared with vehicle-treated mice. PAP-1 preserved perihematomal neurons, producing an approximately 2.9-fold increase in NeuN-positive neuronal density on day 7. Furthermore, PAP-1 suppressed Kv1.3 expression, reduced CD16/32-positive M1-like microglia, enhanced CD206-positive M2-like microglial polarization beginning on day 1, increased the M2/M1 ratio, and significantly improved sensorimotor and locomotor performance across all behavioral assessments. These findings demonstrate that selective Kv1.3 inhibition effectively attenuated neuroinflammation, accelerated hematoma resolution, and promoted functional recovery after experimental sICH. Conclusion: Selective inhibition of Kv1.3 with PAP-1 promoted a favorable shift toward an immunomodulatory microglial phenotype, reduced hematoma burden, preserved perihematomal neurons, and accelerated neurological recovery following collagenase-induced sICH. The integration of histological, immunological, and functional outcomes provides strong evidence supporting Kv1.3 as a promising therapeutic target for early intervention after hemorrhagic stroke. Although the study was limited to male mice, was restricted to a 7-day observation period, and lacked detailed downstream mechanistic analyses, the findings establish a robust preclinical foundation for future investigations into long-term functional recovery, molecular signaling pathways, and translational evaluation of Kv1.3-targeted therapies in sICH. Keywords: collagenase-induced intracerebral hemorrhage, hemorrhagic stroke, Kv1.3, microglia polarization, neuro-inflammation, neuroprotection, PAP-1, spontaneous intracerebral hemorrhage.

1 January 2026 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
NMNipaporn Muangchan
Nipaporn Muangchan
SKSuwattanee Kooptiwut
Suwattanee Kooptiwut
AVAnchalee Vattarakorn
Anchalee Vattarakorn
BYBancha Yingngam
Bancha Yingngam
KSKanchana Suksri
Kanchana Suksri
Cratoxylum formosum (CF) is a phenolic‐rich plant and exhibits in vitro antioxidant properties, yet its in vivo therapeutic potential remains uncharacterized. This study evaluated the antidiabetic efficacy of an ethanolic CF leaf extract using high‐fat diet/streptozotocin‐induced diabetic mice, complemented by enzymatic and INS‐1 rat insulinoma cell line assays. This study found that 5‐O‐caffeoylquinic acid (5‐CQA) was identified as the major phenolic compound in the CF leaf extract. In vitro, CF extract inhibited α‐amylase and α‐glucosidase activities and protected INS‐1 cells from high‐glucose‐induced cytotoxicity. In diabetic mice, CF extract administration attenuated hyperglycemia, partially preserved serum insulin and C‐peptide levels, and suppressed serum neuropeptide Y (NPY) concentrations. Histological analysis confirmed the preservation of pancreatic islet architecture and pancreatic β‐cell mass. These findings indicate that CF extract supports glycemic regulation and pancreatic β‐cell preservation, warranting further exploration as a candidate for diabetes management.